Hard-to-heal diabetes-related foot ulcers: current challenges and future prospects

被引:4
|
作者
Nube, Vanessa [1 ]
Frank, Georgina [1 ]
White, Jessica [1 ]
Stubbs, Sarah [1 ]
Nannery, Sara [2 ]
Pfrunder, Louise [2 ]
Twigg, Stephen M. [3 ]
McLennan, Susan V. [4 ]
机构
[1] Sydney Local Hlth Dist, Dept Podiatry, Camperdown, NSW, Australia
[2] Royal Prince Alfred Hosp, Diabet Ctr High Risk Foot Serv, Camperdown, NSW, Australia
[3] Univ Sydney, Sydney Med Sch, Discipline Med, Sydney, NSW, Australia
[4] Royal Prince Alfred Hosp, Dept Endocrinol, Sydney, NSW, Australia
来源
CHRONIC WOUND CARE MANAGEMENT AND RESEARCH | 2016年 / 3卷
关键词
diabetic foot; healing; infection; delayed treatment; referral;
D O I
10.2147/CWCMR.S84990
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Diabetes-related foot ulceration is a frequent cause for hospital admission and the leading cause of nontraumatic lower limb amputation, placing a high burden on the health system, patient, and their families. Considerable advances in treatments and the establishment of specialized services and teams have improved healing rates and reduced unnecessary amputations. However, amputation rates remain high in some areas, with unacceptable variations within countries yet to be resolved. Specific risk factors including infection, ischemia, ulcer size, depth, and duration as well as probing to bone (or osteomyelitis), location of ulcer, sensory loss, deformity (and high plantar pressure), advanced age, number of ulcers present, and renal disease are associated with poor outcome and delayed healing. To assist in prediction of difficult-to-heal ulcers, more than 13 classification systems have been developed. Ulcer depth (or size), infection, and ischemia are the most common risk factors identified. High-quality treatment protocols and guidelines exist to facilitate best practice in the standard of care. Under these conditions, 66%-77% of foot ulcers will heal. The remaining proportion represents a group unlikely to heal and who will live with a non-healing wound or undergo amputation. The authors have applied their experience of managing patients in this discussion of why some ulcers are harder to heal. The article explores the effects of patient non-adherence to treatment, comorbid mental illness, a failure of research to be translated into the everyday practice of many clinicians, and the impact of delayed access to specialized treatment. These factors when combined with the main published risk factors of size, infection, ischemia and pressure are perceived as critical barriers to healing.
引用
收藏
页码:133 / 146
页数:14
相关论文
共 50 条
  • [31] Cost-effectiveness of ChloraSolv in treating hard-to-heal venous leg ulcers
    Guest, Julian F.
    Apelqvist, Jan
    JOURNAL OF WOUND CARE, 2024, 33 (01) : 4 - 13
  • [32] Pain and analgaesics in patients with hard-to-heal ulcers: using telemedicine or standard consultations
    Wickstrom, Hanna
    Oien, Rut F.
    Midlov, Patrik
    Anderberg, Peter
    Fagerstrom, Cecilia
    JOURNAL OF WOUND CARE, 2020, 29 (08) : S18 - S27
  • [33] Objective analysis of heterologous collagen efficacy in hard-to-heal venous leg ulcers
    Bertone, MariaStefania
    Dini, Valentina
    Romanelli, Paolo
    Rizzello, Franco
    Romanelli, Marco
    WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE, 2008, 20 (09): : 245 - 249
  • [34] Novel Treatment for Hard-to-Heal Chronic Plantar Ulcers in Hansen's Disease
    Upadya, Gatha M.
    Govindarajan, Srinidhi
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2019, 13 (03) : WD01 - WD03
  • [35] An economic assessment of Apligraf® (Graftskin) for the treatment of hard-to-heal venous leg ulcers
    Schonfeld, WH
    Villa, KF
    Fastenau, JM
    Mazonson, PD
    Falanga, V
    WOUND REPAIR AND REGENERATION, 2000, 8 (04) : 251 - 257
  • [36] Australian guideline on wound classification of diabetes-related foot ulcers: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease
    Hamilton, Emma J.
    Scheepers, Joanna
    Ryan, Hayley
    Perrin, Byron M.
    Charles, James
    Cheney, Jane
    Twigg, Stephen M.
    JOURNAL OF FOOT AND ANKLE RESEARCH, 2021, 14 (01)
  • [37] The LeucoPatch® system in the management of hard-to-heal diabetic foot ulcers: a multicentre, multinational, observer-blinded, randomised controlled trial
    Game, F.
    Jeffcoate, W.
    Tarnow, L.
    Jacobsen, J.
    Whitham, D.
    Harrison, E.
    Ellender, S.
    Londahl, M.
    DIABETOLOGIA, 2018, 61 : S6 - S6
  • [38] Australian guideline on wound classification of diabetes-related foot ulcers: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease
    Emma J. Hamilton
    Joanna Scheepers
    Hayley Ryan
    Byron M. Perrin
    James Charles
    Jane Cheney
    Stephen M. Twigg
    Journal of Foot and Ankle Research, 14
  • [39] Treating hard-to-heal skin and nail onychomycosis of diabetic foot with plasma therapy
    Terabe, Yuta
    Kaneko, Nobuhito
    Ando, Hiroshi
    DERMATOLOGIC THERAPY, 2021, 34 (06)
  • [40] Efficacy of autologous platelet-rich plasma gel in patients with hard-to-heal diabetic foot ulcers: a multicentre study in Japan
    Ohura, Norihiko
    Kimura, Chu
    Ando, Hiroshi
    Yuzuriha, Shunsuke
    Furukawa, Masahide
    Higashita, Ryuji
    Ayabe, Shinobu
    Tsuji, Yoriko
    Fujii, Miki
    Terabe, Yuta
    Sakisaka, Masanobu
    Iwashina, Yuki
    Nakanishi, Arata
    Sasaki, Shigeru
    Hasegawa, Toshio
    Kawauchi, Tsukasa
    Hisamichi, Katsuya
    JOURNAL OF WOUND CARE, 2024, 33 (07) : 484 - 494